---
title: "IVDR rule 4: Self-testing and near-patient testing"
url: https://normiq.app/en/classification/ivdr/rule-4
language: en
updated: 2026-11-15
---

# IVDR rule 4: Self-testing and near-patient testing

IVDR · Annex VIII, Section 2.4 · CLASSIFICATION RULES

Updated on November 15, 2026

## Official text

Devices intended for self-testing are classified as class C, except for devices for the detection of pregnancy, for fertility testing and for determining cholesterol level, and devices for the detection of glucose, erythrocytes, leucocytes and bacteria in urine, which are classified as class B.

Devices intended for near-patient testing are classified in their own right.

IVDR, Annex VIII, Section 2.4, consolidated version of January 10, 2025.

Short link: [normiq.app/en/ivdr/annexe/viii/4](https://normiq.app/en/ivdr/annexe/viii/4)

## In plain words

A self-testing device is in class C, except devices for the detection of pregnancy, fertility testing, determining cholesterol level and detecting glucose, erythrocytes, leucocytes and bacteria in urine, which are in class B. A near-patient testing device is classified in its own right: the rule gives it no class.

Explanation written by Normiq; only the official text above is authoritative.

## Definitions the rule relies on

- IVDR, Article 2, point 5

  ‘device for self-testing’ means any device intended by the manufacturer to be used by lay persons, including devices used for testing services offered to lay persons by means of information society services;

- IVDR, Article 2, point 6

  ‘device for near-patient testing’ means any device that is not intended for self-testing but is intended to perform testing outside a laboratory environment, generally near to, or at the side of, the patient by a health professional;

## Examples from the MDCG guidance

The guidance lists these examples under rule 4 (MDCG 2020-16 rev.5). It is not legally binding, and the class always depends on the intended purpose of the device (Annex VIII, Section 1.1).

### Class C

- Meters and strips (containing integrated testing reagent) for self-testing of capillary blood glucose are in class C.

  MDCG 2020-16 rev.5, 4, Rule 4(a), p. 37

- Self-testing devices for blood clotting, e.g. measurement of International Normalised Ratio (INR) are in class C.

  MDCG 2020-16 rev.5, 4, Rule 4(a), p. 37

## Classes and Normiq roadmaps

Rule 4 assigns: Class B, Class C. For each, the Normiq roadmap on every market where Annex VIII applies.

### Class B

- [European Union 15 phases · 61 steps · estimated duration 180 days See the roadmap →](https://normiq.app/en/roadmap/eu/ivd-class-b)
- [Switzerland 16 phases · 59 steps · estimated duration 90 days See the roadmap →](https://normiq.app/en/roadmap/switzerland/ivd-class-b)
- [European Union and Switzerland 16 phases · 64 steps · estimated duration 225 days See the roadmap →](https://normiq.app/en/roadmap/eu-switzerland/ivd-class-b)

### Class C

- [European Union 15 phases · 63 steps · estimated duration 270 days See the roadmap →](https://normiq.app/en/roadmap/eu/ivd-class-c)
- [Switzerland 16 phases · 61 steps · estimated duration 135 days See the roadmap →](https://normiq.app/en/roadmap/switzerland/ivd-class-c)
- [European Union and Switzerland 16 phases · 66 steps · estimated duration 330 days See the roadmap →](https://normiq.app/en/roadmap/eu-switzerland/ivd-class-c)

## The same rule in Switzerland

> Devices shall be divided into classes A, B, C and D, taking into account the intended purpose of the devices and their inherent risks. This classification must comply with the provisions of Annex VIII to EU-IVDR.

Fedlex’s English translation, which has no legal force: the ordinance is official only in French, German and Italian.

[Art. 14 IvDO](https://www.fedlex.admin.ch/eli/cc/2022/291/en#art_14)

## Classify your device

The tool asks the questions of the 7 rules of the IVDR, one at a time, and gives the indicative class with the rule and its text.

[Open the classification tool](https://normiq.app/en/classification#outil)

## Official sources

- [IVDR, consolidated version of January 10, 2025 (02017R0746-20250110), EUR-Lex](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:02017R0746-20250110)
- [MDCG 2020-16 rev.5, “Guidance on Classification Rules for In Vitro Diagnostic Medical Devices under Regulation (EU) 2017/746”, September 2026, p. 37](https://health.ec.europa.eu/document/download/12f9756a-1e0d-4aed-9783-d948553f1705_en?filename=md_mdcg_2020_guidance_classification_ivd-md_en.pdf)
